RELL1 is upregulated in gliomas and is a poor prognostic indicator for survival, as bioinformatic analysis revealed that RELL1 is expressed more prominently in metastatic brain tumors that have a poor prognosis [70]. This evidence concerns the gene RELL1 and central nervous system cancer.